Royalty Pharma Plc (RPRX)
64.76
+0.90
(+1.41%)
USD |
NASDAQ |
Oct 26, 16:00
64.88
+0.12
(+0.19%)
After-Hours: 17:46
Royalty Pharma Market Cap : 28.87B for Oct. 26, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 28.47B |
| October 22, 2026 | 28.42B |
| October 21, 2026 | 27.70B |
| October 20, 2026 | 27.75B |
| October 19, 2026 | 26.87B |
| October 16, 2026 | 27.17B |
| October 15, 2026 | 26.58B |
| October 14, 2026 | 26.29B |
| October 13, 2026 | 25.22B |
| October 12, 2026 | 25.76B |
| October 09, 2026 | 25.38B |
| October 08, 2026 | 25.06B |
| October 07, 2026 | 25.30B |
| October 06, 2026 | 25.16B |
| October 05, 2026 | 25.26B |
| October 02, 2026 | 25.48B |
| October 01, 2026 | 25.69B |
| September 30, 2026 | 26.01B |
| September 29, 2026 | 25.95B |
| September 28, 2026 | 26.02B |
| September 25, 2026 | 25.95B |
| September 24, 2026 | 25.98B |
| September 23, 2026 | 25.70B |
| September 22, 2026 | 26.08B |
| September 21, 2026 | 26.05B |
| Date | Value |
|---|---|
| September 18, 2026 | 26.04B |
| September 17, 2026 | 26.27B |
| September 16, 2026 | 26.06B |
| September 15, 2026 | 26.06B |
| September 14, 2026 | 26.32B |
| September 11, 2026 | 26.13B |
| September 10, 2026 | 26.19B |
| September 09, 2026 | 27.01B |
| September 08, 2026 | 27.01B |
| September 04, 2026 | 28.51B |
| September 03, 2026 | 28.47B |
| September 02, 2026 | 28.13B |
| September 01, 2026 | 27.78B |
| August 31, 2026 | 27.37B |
| August 28, 2026 | 27.12B |
| August 27, 2026 | 27.60B |
| August 26, 2026 | 27.55B |
| August 25, 2026 | 27.67B |
| August 24, 2026 | 27.34B |
| August 21, 2026 | 27.33B |
| August 20, 2026 | 27.00B |
| August 19, 2026 | 27.52B |
| August 18, 2026 | 26.61B |
| August 17, 2026 | 26.50B |
| August 14, 2026 | 26.12B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 347.08B |
| Johnson & Johnson | 641.50B |
| ANI Pharmaceuticals, Inc. | 1.652B |
| Corcept Therapeutics, Inc. | 9.414B |
| Veru, Inc. | 37.85M |
Market Cap Related Metrics
| PE Ratio | 34.48 |
| PS Ratio | 13.42 |
| Price to Book Value | 4.225 |
| Price to Free Cash Flow | 55.56 |
| Price | 64.76 |
| Earnings Yield | 2.90% |
| Operating PE Ratio | 21.53 |
| Normalized PE Ratio | 36.67 |